PLCG1 |
PLCG1, PLC1: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 |
STK38 |
STK38, NDR1: Serine/threonine-protein kinase 38 |
0.265 |
Evidence |
|
PSTPIP1 |
PSTPIP1, CD2BP1: Proline-serine-threonine phosphatase-interacting protein 1 |
RASA3 |
RASA3: Ras GTPase-activating protein 3 |
0.265 |
Evidence |
|
NFATC1 |
IPI00336007 |
H1FX |
H1FX: Histone H1x |
0.265 |
Evidence |
|
RBM6 |
RBM6, DEF3: RNA-binding protein 6 |
PABPC4 |
PABPC4, APP1, PABP4: Polyadenylate-binding protein 4 |
0.265 |
Evidence |
|
GTF2F2 |
IPI00329767 |
TRIM28 |
TRIM28, KAP1, RNF96, TIF1B: Transcription intermediary factor 1-beta |
0.265 |
Evidence |
|
HLA-DMA |
DMA, HLA-DMA, DAQB-96B10.1-001, DASS-67H14.8-001, XXbac-BCX136A3.1-001, XXbac-BP |
FLT3 |
FLT3, STK1: FL cytokine receptor precursor |
0.265 |
Evidence |
|
KDR |
KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor |
IL1RL1 |
IL1RL1, DER4, ST2, T1: Interleukin-1 receptor-like 1 precursor |
0.265 |
Evidence |
|
S100B |
S100B: Protein S100-B |
SPTAN1 |
IPI00413728 |
0.265 |
Evidence |
|
ROCK1 |
ROCK1: Rho-associated protein kinase 1 |
OSBPL11 |
OSBPL11, ORP11, OSBP12: Oxysterol-binding protein-related protein 11 |
0.265 |
Evidence |
|
MAG |
MAG, GMA: Myelin-associated glycoprotein precursor |
CD82 |
CD82, KAI1, SAR2, ST6, TSPAN27: CD82 antigen |
0.265 |
Evidence |
|
JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
MAP2K3 |
MAP2K3, MEK3, MKK3, PRKMK3: Dual specificity mitogen-activated protein kinase ki |
0.265 |
Evidence |
|
DUSP3 |
DUSP3, VHR: Dual specificity protein phosphatase 3 |
CDK5 |
CDK5: Cell division protein kinase 5 |
0.265 |
Evidence |
|
PLEK |
PLEK, P47: Pleckstrin |
SOS1 |
SOS1: Son of sevenless homolog 1 |
0.265 |
Evidence |
|
MAP4K1 |
MAP4K1, HPK1: Mitogen-activated protein kinase kinase kinase kinase 1 |
CCNL1 |
CCNL1, BM-001, UNQ530/PRO1073: Cyclin-L1 |
0.265 |
Evidence |
|
CFB |
CFB, BF, BFD: Complement factor B precursor |
C1S |
C1S: Complement C1s subcomponent precursor |
0.265 |
Evidence |
|
MAP2K1 |
MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 |
OSBPL11 |
OSBPL11, ORP11, OSBP12: Oxysterol-binding protein-related protein 11 |
0.265 |
Evidence |
|
VAV1 |
VAV1, VAV: Proto-oncogene vav |
RIPK1 |
RIPK1, RIP: Receptor-interacting serine/threonine-protein kinase 1 |
0.265 |
Evidence |
|
PIK3CD |
PIK3CD: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta i |
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
0.265 |
Evidence |
|
MAP3K8 |
MAP3K8, COT, ESTF: Mitogen-activated protein kinase kinase kinase 8 |
CENTB2 |
CENTB2, KIAA0041: Centaurin-beta 2 |
0.265 |
Evidence |
|
CFI |
CFI, IF: Complement factor I precursor |
C8B |
C8B: Complement component C8 beta chain precursor |
0.265 |
Evidence |
|
RIPK1 |
RIPK1, RIP: Receptor-interacting serine/threonine-protein kinase 1 |
SLA |
SLA, SLAP, SLAP1: SRC-like-adapter |
0.265 |
Evidence |
|
STK16 |
IPI00480017 |
PSMA2 |
PSMA2, PSC3: Proteasome subunit alpha type-2 |
0.265 |
Evidence |
|
LIMK2 |
LIMK2: LIM domain kinase 2 |
PTEN |
PTEN, MMAC1, TEP1: Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and du |
0.265 |
Evidence |
|
CD7 |
CD7: T-cell antigen CD7 precursor |
CD3G |
CD3G, T3G: T-cell surface glycoprotein CD3 gamma chain precursor |
0.265 |
Evidence |
|
BARD1 |
BARD1: BRCA1-associated RING domain protein 1 |
JMJD1A |
JMJD1A, JHDM2A, JMJD1, KIAA0742: JmjC domain-containing histone demethylation pr |
0.265 |
Evidence |
|